PYC THERAPEUTICS LIMITED — Director's Dealing 2011

Jul 31, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	JOHN DOUGLAS WILSON
Date of last notice	2 May 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case odisclosed in this p	Note: In the case odisclosed in this p	f a company, interests whichart.	come within paragraph (i) of th	come within paragraph (i) of th	e definition of “notifiable intere	st of a director” should be	st of a director” should be
Direct or ind
	Direct or ind	rect interest		IN	DIRECT
	Nature of ind(including re	irect interestgistered holder)		GIDi	LLESPIE NOMINEErector & Shareholder	S LTD
	Note: Provide deinterest.	tails of the circumstances g	iving rise to the relevant
	Date of chan	ge		31	July 2011
	No of securi	ties held prior to chan	ge	IN	DIRECT
	.			30	0,000 UNLISTED OP	TIONS
				6110	8,337 ESOP OPTION000 CONVERTIBLE	SNOTES
	Class			O	,RDINARY SHARES
	**Number acq **	uired		NI	L
	Number disp	osed		30	0,000 UNLISTED OP	TIONS
	Value/ConsiNote: If conside	erationration is non‐cash, provid	e details and estimated	NI	L - Lapsed unexercis	ed
	valuation
	No. of securi	ties held after change		IN25	DIRECT0,000 ORDINARY S	HARES
				61	8,337 ESOP OPTION	S

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change LAPSE OF OPTIONS ON EXPIRY Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐ back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	N/A
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011